Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III [Health Services and Outcomes Research]

ConclusionsDetailed economic and resource utilization data from IMS III provide powerful evidence for the large effect that patient outcome has on the economic value of medical and endovascular reperfusion therapies. These data can be used to inform process improvements for stroke care and to estimate the cost‐effectiveness of endovascular therapy in the US health system for stroke intervention trials.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Registration number: NCT00359424.

Source: JAHA:Journal of the American Heart Association - May 8, 2017 Category: Cardiology Authors: Simpson, K. N., Simpson, A. N., Mauldin, P. D., Palesch, Y. Y., Yeatts, S. D., Kleindorfer, D., Tomsick, T. A., Foster, L. D., Demchuk, A. M., Khatri, P., Hill, M. D., Jauch, E. C., Jovin, T. G., Yan, B., von Kummer, R., Molina, C. A., Goyal, M., Schonewi Tags: Cost-Effectiveness, Health Services, Cerebrovascular Procedures, Ischemic Stroke Original Research Source Type: research